Asston Pharma FY26 Revenue ₹3,158.43 Lakhs, Profit ₹386.52 Lakhs

Asston Pharmaceuticals Limited has released its 7th Annual Report for the Financial Year 2025-26. The company reported robust growth, with total revenue increasing by 23.32% to ₹3,158.43 lakhs from ₹2,561.02 lakhs in the previous year. Net profit for the fiscal year stood at ₹386.52 lakhs. The report highlights the company's strategic initiatives, including expanding its Global Specialty product pipeline and strengthening its market presence in India and other emerging markets. Asston Pharmaceuticals emphasizes its commitment to quality, innovation, and sustainable growth amidst a dynamic and regulated global pharmaceutical landscape. The company also noted progress in sustainable sourcing, resource utilization, and energy-efficient operations.